k-med limited Company Information
Company Number
05517042
Next Accounts
Dec 2025
Shareholders
ravindra bala singh
mr ajit kumar
Group Structure
View All
Industry
Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores
Registered Address
unit 3a falcon way, feltham, middlesex, TW14 0XJ
Website
www.kmed.co.ukk-med limited Estimated Valuation
Pomanda estimates the enterprise value of K-MED LIMITED at £342.5k based on a Turnover of £902.6k and 0.38x industry multiple (adjusted for size and gross margin).
k-med limited Estimated Valuation
Pomanda estimates the enterprise value of K-MED LIMITED at £0 based on an EBITDA of £-486.5k and a 3.92x industry multiple (adjusted for size and gross margin).
k-med limited Estimated Valuation
Pomanda estimates the enterprise value of K-MED LIMITED at £3.7m based on Net Assets of £1.7m and 2.14x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
K-med Limited Overview
K-med Limited is a live company located in middlesex, TW14 0XJ with a Companies House number of 05517042. It operates in the retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. sector, SIC Code 47749. Founded in July 2005, it's largest shareholder is ravindra bala singh with a 50% stake. K-med Limited is a mature, small sized company, Pomanda has estimated its turnover at £902.6k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
K-med Limited Health Check
Pomanda's financial health check has awarded K-Med Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 8 areas for improvement. Company Health Check FAQs


3 Strong

1 Regular

8 Weak

Size
annual sales of £902.6k, make it smaller than the average company (£12.6m)
- K-med Limited
£12.6m - Industry AVG

Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (7.4%)
- K-med Limited
7.4% - Industry AVG

Production
with a gross margin of 29%, this company has a higher cost of product (37.2%)
- K-med Limited
37.2% - Industry AVG

Profitability
an operating margin of -53.9% make it less profitable than the average company (5.8%)
- K-med Limited
5.8% - Industry AVG

Employees
with 9 employees, this is below the industry average (49)
9 - K-med Limited
49 - Industry AVG

Pay Structure
on an average salary of £58.4k, the company has an equivalent pay structure (£58.4k)
- K-med Limited
£58.4k - Industry AVG

Efficiency
resulting in sales per employee of £100.3k, this is less efficient (£264.9k)
- K-med Limited
£264.9k - Industry AVG

Debtor Days
it gets paid by customers after 77 days, this is later than average (48 days)
- K-med Limited
48 days - Industry AVG

Creditor Days
its suppliers are paid after 134 days, this is slower than average (41 days)
- K-med Limited
41 days - Industry AVG

Stock Days
it holds stock equivalent to 101 days, this is more than average (63 days)
- K-med Limited
63 days - Industry AVG

Cash Balance
has cash to cover current liabilities for 353 weeks, this is more cash available to meet short term requirements (13 weeks)
353 weeks - K-med Limited
13 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 12%, this is a lower level of debt than the average (46.9%)
12% - K-med Limited
46.9% - Industry AVG
K-MED LIMITED financials

K-Med Limited's latest turnover from March 2024 is estimated at £902.6 thousand and the company has net assets of £1.7 million. According to their latest financial statements, K-Med Limited has 9 employees and maintains cash reserves of £1.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Jul 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||||
Other Income Or Grants | ||||||||||||||||
Cost Of Sales | ||||||||||||||||
Gross Profit | ||||||||||||||||
Admin Expenses | ||||||||||||||||
Operating Profit | ||||||||||||||||
Interest Payable | ||||||||||||||||
Interest Receivable | ||||||||||||||||
Pre-Tax Profit | ||||||||||||||||
Tax | ||||||||||||||||
Profit After Tax | ||||||||||||||||
Dividends Paid | ||||||||||||||||
Retained Profit | ||||||||||||||||
Employee Costs | ||||||||||||||||
Number Of Employees | 9 | 6 | 5 | 5 | 5 | 5 | ||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Jul 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 2,306 | |||||||||||||||
Intangible Assets | ||||||||||||||||
Investments & Other | ||||||||||||||||
Debtors (Due After 1 year) | ||||||||||||||||
Total Fixed Assets | 2,306 | |||||||||||||||
Stock & work in progress | 178,008 | 52,691 | 39,830 | 34,736 | 60,874 | 70,227 | 54,427 | 67,502 | 58,150 | 34,530 | 32,867 | 29,383 | 21,269 | 39,875 | ||
Trade Debtors | 192,101 | 317,293 | 485,728 | 136,076 | 413,389 | 334,613 | 336,680 | 285,080 | 292,313 | 103,764 | 118,151 | 201,403 | 106,924 | 30,919 | ||
Group Debtors | ||||||||||||||||
Misc Debtors | ||||||||||||||||
Cash | 1,607,642 | 1,974,849 | 1,587,645 | 2,604,220 | 311,614 | 297,944 | 195,143 | 252,446 | 148,695 | 252,775 | 27,315 | 226,424 | 142,213 | 168,646 | ||
misc current assets | ||||||||||||||||
total current assets | 1,977,751 | 2,344,833 | 2,113,203 | 2,775,032 | 785,877 | 702,784 | 586,250 | 605,028 | 499,158 | 391,069 | 178,333 | 457,210 | 270,406 | 239,440 | ||
total assets | 1,977,751 | 2,344,833 | 2,113,203 | 2,775,032 | 785,877 | 702,784 | 586,250 | 607,334 | 499,158 | 391,069 | 178,333 | 457,210 | 270,406 | 239,440 | ||
Bank overdraft | ||||||||||||||||
Bank loan | ||||||||||||||||
Trade Creditors | 236,688 | 200,740 | 361,939 | 391,407 | 394,365 | 278,467 | 303,498 | 136,897 | 96,031 | 60,118 | 375,342 | 224,148 | 218,665 | |||
Group/Directors Accounts | ||||||||||||||||
other short term finances | ||||||||||||||||
hp & lease commitments | ||||||||||||||||
other current liabilities | ||||||||||||||||
total current liabilities | 236,688 | 200,740 | 361,939 | 391,407 | 394,365 | 278,467 | 303,498 | 136,897 | 96,031 | 60,118 | 375,342 | 224,148 | 218,665 | |||
loans | ||||||||||||||||
hp & lease commitments | ||||||||||||||||
Accruals and Deferred Income | ||||||||||||||||
other liabilities | 50,000 | 39,672 | 76,676 | 113,680 | 200,685 | 166,678 | ||||||||||
provisions | 10,526 | 24,511 | 378,898 | 25,575 | 8,884 | 9,119 | 7,044 | 6,643 | ||||||||
total long term liabilities | 10,526 | 24,511 | 428,898 | 25,575 | 48,556 | 85,795 | 120,724 | 207,328 | 166,678 | |||||||
total liabilities | 236,688 | 211,266 | 24,511 | 790,837 | 416,982 | 442,921 | 364,262 | 424,222 | 344,225 | 262,709 | 60,118 | 375,342 | 224,148 | 218,665 | ||
net assets | 1,741,063 | 2,133,567 | 2,088,692 | 1,984,195 | 368,895 | 259,863 | 221,988 | 183,112 | 154,933 | 128,360 | 118,215 | 81,868 | 46,258 | 20,775 | ||
total shareholders funds | 1,741,063 | 2,133,567 | 2,088,692 | 1,984,195 | 368,895 | 259,863 | 221,988 | 183,112 | 154,933 | 128,360 | 118,215 | 81,868 | 46,258 | 20,775 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Jul 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||||
Operating Profit | ||||||||||||||||
Depreciation | ||||||||||||||||
Amortisation | ||||||||||||||||
Tax | ||||||||||||||||
Stock | 125,317 | 12,861 | 5,094 | -26,138 | -9,353 | 15,800 | -13,075 | 9,352 | 23,620 | 1,663 | 3,484 | 8,114 | -18,606 | 39,875 | ||
Debtors | -125,192 | -168,435 | 349,652 | -277,313 | 78,776 | -2,067 | 51,600 | -7,233 | 188,549 | -14,387 | -83,252 | 94,479 | 76,005 | 30,919 | ||
Creditors | 35,948 | 200,740 | -361,939 | -29,468 | -2,958 | 115,898 | -25,031 | 166,601 | 40,866 | 35,913 | -315,224 | 151,194 | 5,483 | 218,665 | ||
Accruals and Deferred Income | ||||||||||||||||
Deferred Taxes & Provisions | -10,526 | -13,985 | -354,387 | 353,323 | 16,691 | -235 | 2,075 | 401 | 6,643 | |||||||
Cash flow from operations | ||||||||||||||||
Investing Activities | ||||||||||||||||
capital expenditure | ||||||||||||||||
Change in Investments | ||||||||||||||||
cash flow from investments | ||||||||||||||||
Financing Activities | ||||||||||||||||
Bank loans | ||||||||||||||||
Group/Directors Accounts | ||||||||||||||||
Other Short Term Loans | ||||||||||||||||
Long term loans | ||||||||||||||||
Hire Purchase and Lease Commitments | ||||||||||||||||
other long term liabilities | -50,000 | 50,000 | -39,672 | -37,004 | -37,004 | -87,005 | 34,007 | 166,678 | ||||||||
share issue | ||||||||||||||||
interest | ||||||||||||||||
cash flow from financing | ||||||||||||||||
cash and cash equivalents | ||||||||||||||||
cash | -367,207 | 387,204 | -1,016,575 | 2,292,606 | 13,670 | 102,801 | -57,303 | 103,751 | -104,080 | 225,460 | -199,109 | 84,211 | -26,433 | 168,646 | ||
overdraft | ||||||||||||||||
change in cash | -367,207 | 387,204 | -1,016,575 | 2,292,606 | 13,670 | 102,801 | -57,303 | 103,751 | -104,080 | 225,460 | -199,109 | 84,211 | -26,433 | 168,646 |
k-med limited Credit Report and Business Information
K-med Limited Competitor Analysis

Perform a competitor analysis for k-med limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in TW14 area or any other competitors across 12 key performance metrics.
k-med limited Ownership
K-MED LIMITED group structure
K-Med Limited has no subsidiary companies.
Ultimate parent company
K-MED LIMITED
05517042
k-med limited directors
K-Med Limited currently has 4 directors. The longest serving directors include Mr Ajit Kumar (Feb 2007) and Ms Kabita Kroft (Feb 2007).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Ajit Kumar | England | 71 years | Feb 2007 | - | Director |
Ms Kabita Kroft | England | 46 years | Feb 2007 | - | Director |
Mrs. Ravindra Singh | England | 69 years | Feb 2007 | - | Director |
Mr Andrew Kruiniger | England | 45 years | Jan 2024 | - | Director |
P&L
March 2024turnover
902.6k
-5%
operating profit
-486.5k
0%
gross margin
29.1%
+2.31%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
1.7m
-0.18%
total assets
2m
-0.16%
cash
1.6m
-0.19%
net assets
Total assets minus all liabilities
k-med limited company details
company number
05517042
Type
Private limited with Share Capital
industry
47749 - Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores
incorporation date
July 2005
age
20
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
unit 3a falcon way, feltham, middlesex, TW14 0XJ
Bank
-
Legal Advisor
-
k-med limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to k-med limited.
k-med limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for K-MED LIMITED. This can take several minutes, an email will notify you when this has completed.
k-med limited Companies House Filings - See Documents
date | description | view/download |
---|